The global Ropivacaine Injection market was valued at US$ 895.2 million in 2022 and is projected to reach US$ 1357.2 million by 2029, at a CAGR of 6.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
2 mg/mL (0.2%) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ropivacaine Injection include Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP and Zhejiang Xianju Pharmaceutical Co.,Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Ropivacaine injection is used to cause numbness or loss of feeling in patients before and during surgery or labor and delivery. It is also used to relieve acute pain. Ropivacaine is a local anesthetic and does not cause loss of consciousness.
This report aims to provide a comprehensive presentation of the global market for Ropivacaine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ropivacaine Injection. This report contains market size and forecasts of Ropivacaine Injection in global, including the following market information:
Global Ropivacaine Injection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ropivacaine Injection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Ropivacaine Injection companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ropivacaine Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ropivacaine Injection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ropivacaine Injection Market Segment Percentages, by Type, 2022 (%)
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
10 mg/mL (1%)
Global Ropivacaine Injection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ropivacaine Injection Market Segment Percentages, by Application, 2022 (%)
Surgical Anesthesia
Major Nerve Block
Acute Pain Management
Other
Global Ropivacaine Injection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Ropivacaine Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ropivacaine Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ropivacaine Injection revenues share in global market, 2022 (%)
Key companies Ropivacaine Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ropivacaine Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Akorn
Anant Pharmaceuticals
SGPharma
Nephron Pharmaceuticals
Sintetica SA
AstraZeneca
Manus Aktteva Biopharma LLP
Zhejiang Xianju Pharmaceutical Co.,Ltd
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Yangzi River Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ropivacaine Injection, market overview.
Chapter 2: Global Ropivacaine Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Ropivacaine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ropivacaine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ropivacaine Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Ropivacaine Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ropivacaine Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ropivacaine Injection Overall Market Size
2.1 Global Ropivacaine Injection Market Size: 2022 VS 2029
2.2 Global Ropivacaine Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ropivacaine Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Ropivacaine Injection Players in Global Market
3.2 Top Global Ropivacaine Injection Companies Ranked by Revenue
3.3 Global Ropivacaine Injection Revenue by Companies
3.4 Global Ropivacaine Injection Sales by Companies
3.5 Global Ropivacaine Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ropivacaine Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ropivacaine Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ropivacaine Injection Players in Global Market
3.8.1 List of Global Tier 1 Ropivacaine Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Ropivacaine Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ropivacaine Injection Market Size Markets, 2022 & 2029
4.1.2 2 mg/mL (0.2%)
4.1.3 5 mg/mL (0.5%)
4.1.4 7.5 mg/mL (0.75%)
4.1.5 10 mg/mL (1%)
4.2 By Type - Global Ropivacaine Injection Revenue & Forecasts
4.2.1 By Type - Global Ropivacaine Injection Revenue, 2018-2023
4.2.2 By Type - Global Ropivacaine Injection Revenue, 2024-2029
4.2.3 By Type - Global Ropivacaine Injection Revenue Market Share, 2018-2029
4.3 By Type - Global Ropivacaine Injection Sales & Forecasts
4.3.1 By Type - Global Ropivacaine Injection Sales, 2018-2023
4.3.2 By Type - Global Ropivacaine Injection Sales, 2024-2029
4.3.3 By Type - Global Ropivacaine Injection Sales Market Share, 2018-2029
4.4 By Type - Global Ropivacaine Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ropivacaine Injection Market Size, 2022 & 2029
5.1.2 Surgical Anesthesia
5.1.3 Major Nerve Block
5.1.4 Acute Pain Management
5.1.5 Other
5.2 By Application - Global Ropivacaine Injection Revenue & Forecasts
5.2.1 By Application - Global Ropivacaine Injection Revenue, 2018-2023
5.2.2 By Application - Global Ropivacaine Injection Revenue, 2024-2029
5.2.3 By Application - Global Ropivacaine Injection Revenue Market Share, 2018-2029
5.3 By Application - Global Ropivacaine Injection Sales & Forecasts
5.3.1 By Application - Global Ropivacaine Injection Sales, 2018-2023
5.3.2 By Application - Global Ropivacaine Injection Sales, 2024-2029
5.3.3 By Application - Global Ropivacaine Injection Sales Market Share, 2018-2029
5.4 By Application - Global Ropivacaine Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Ropivacaine Injection Market Size, 2022 & 2029
6.2 By Region - Global Ropivacaine Injection Revenue & Forecasts
6.2.1 By Region - Global Ropivacaine Injection Revenue, 2018-2023
6.2.2 By Region - Global Ropivacaine Injection Revenue, 2024-2029
6.2.3 By Region - Global Ropivacaine Injection Revenue Market Share, 2018-2029
6.3 By Region - Global Ropivacaine Injection Sales & Forecasts
6.3.1 By Region - Global Ropivacaine Injection Sales, 2018-2023
6.3.2 By Region - Global Ropivacaine Injection Sales, 2024-2029
6.3.3 By Region - Global Ropivacaine Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Ropivacaine Injection Revenue, 2018-2029
6.4.2 By Country - North America Ropivacaine Injection Sales, 2018-2029
6.4.3 US Ropivacaine Injection Market Size, 2018-2029
6.4.4 Canada Ropivacaine Injection Market Size, 2018-2029
6.4.5 Mexico Ropivacaine Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Ropivacaine Injection Revenue, 2018-2029
6.5.2 By Country - Europe Ropivacaine Injection Sales, 2018-2029
6.5.3 Germany Ropivacaine Injection Market Size, 2018-2029
6.5.4 France Ropivacaine Injection Market Size, 2018-2029
6.5.5 U.K. Ropivacaine Injection Market Size, 2018-2029
6.5.6 Italy Ropivacaine Injection Market Size, 2018-2029
6.5.7 Russia Ropivacaine Injection Market Size, 2018-2029
6.5.8 Nordic Countries Ropivacaine Injection Market Size, 2018-2029
6.5.9 Benelux Ropivacaine Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Ropivacaine Injection Revenue, 2018-2029
6.6.2 By Region - Asia Ropivacaine Injection Sales, 2018-2029
6.6.3 China Ropivacaine Injection Market Size, 2018-2029
6.6.4 Japan Ropivacaine Injection Market Size, 2018-2029
6.6.5 South Korea Ropivacaine Injection Market Size, 2018-2029
6.6.6 Southeast Asia Ropivacaine Injection Market Size, 2018-2029
6.6.7 India Ropivacaine Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Ropivacaine Injection Revenue, 2018-2029
6.7.2 By Country - South America Ropivacaine Injection Sales, 2018-2029
6.7.3 Brazil Ropivacaine Injection Market Size, 2018-2029
6.7.4 Argentina Ropivacaine Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ropivacaine Injection Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Ropivacaine Injection Sales, 2018-2029
6.8.3 Turkey Ropivacaine Injection Market Size, 2018-2029
6.8.4 Israel Ropivacaine Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Ropivacaine Injection Market Size, 2018-2029
6.8.6 UAE Ropivacaine Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Ropivacaine Injection Major Product Offerings
7.1.4 Pfizer Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Akorn
7.2.1 Akorn Company Summary
7.2.2 Akorn Business Overview
7.2.3 Akorn Ropivacaine Injection Major Product Offerings
7.2.4 Akorn Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.2.5 Akorn Key News & Latest Developments
7.3 Anant Pharmaceuticals
7.3.1 Anant Pharmaceuticals Company Summary
7.3.2 Anant Pharmaceuticals Business Overview
7.3.3 Anant Pharmaceuticals Ropivacaine Injection Major Product Offerings
7.3.4 Anant Pharmaceuticals Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.3.5 Anant Pharmaceuticals Key News & Latest Developments
7.4 SGPharma
7.4.1 SGPharma Company Summary
7.4.2 SGPharma Business Overview
7.4.3 SGPharma Ropivacaine Injection Major Product Offerings
7.4.4 SGPharma Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.4.5 SGPharma Key News & Latest Developments
7.5 Nephron Pharmaceuticals
7.5.1 Nephron Pharmaceuticals Company Summary
7.5.2 Nephron Pharmaceuticals Business Overview
7.5.3 Nephron Pharmaceuticals Ropivacaine Injection Major Product Offerings
7.5.4 Nephron Pharmaceuticals Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.5.5 Nephron Pharmaceuticals Key News & Latest Developments
7.6 Sintetica SA
7.6.1 Sintetica SA Company Summary
7.6.2 Sintetica SA Business Overview
7.6.3 Sintetica SA Ropivacaine Injection Major Product Offerings
7.6.4 Sintetica SA Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.6.5 Sintetica SA Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Ropivacaine Injection Major Product Offerings
7.7.4 AstraZeneca Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Manus Aktteva Biopharma LLP
7.8.1 Manus Aktteva Biopharma LLP Company Summary
7.8.2 Manus Aktteva Biopharma LLP Business Overview
7.8.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Major Product Offerings
7.8.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.8.5 Manus Aktteva Biopharma LLP Key News & Latest Developments
7.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
7.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Company Summary
7.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Business Overview
7.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Major Product Offerings
7.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Key News & Latest Developments
7.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
7.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Company Summary
7.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Business Overview
7.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Major Product Offerings
7.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.11 Yangzi River Pharmaceutical Group
7.11.1 Yangzi River Pharmaceutical Group Company Summary
7.11.2 Yangzi River Pharmaceutical Group Ropivacaine Injection Business Overview
7.11.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Major Product Offerings
7.11.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.11.5 Yangzi River Pharmaceutical Group Key News & Latest Developments
7.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
7.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Summary
7.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Business Overview
7.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Major Product Offerings
7.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Key News & Latest Developments
7.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
7.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Company Summary
7.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Business Overview
7.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Major Product Offerings
7.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales and Revenue in Global (2018-2023)
7.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Key News & Latest Developments
8 Global Ropivacaine Injection Production Capacity, Analysis
8.1 Global Ropivacaine Injection Production Capacity, 2018-2029
8.2 Ropivacaine Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Ropivacaine Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ropivacaine Injection Supply Chain Analysis
10.1 Ropivacaine Injection Industry Value Chain
10.2 Ropivacaine Injection Upstream Market
10.3 Ropivacaine Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ropivacaine Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report